Reports Q1 cash and cash equivalents $124.2M, with no debt.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SAVA:
- Cassava Sciences (NASDAQ:SAVA): Cracking Alzheimer’s or Succumbing to Short Sellers?
- Cassava Sciences Announces Over $125 Million Raised from Warrant Distribution
- Cassava Sciences call volume above normal and directionally bullish
- Largest borrow rate increases among liquid names
- Cassava Sciences announces last day to trade SAVAW warrants on Nasdaq